NOVEL Study
Start date:April 2019 End date:
April 2021 Co-ordinated by:
LumiraDx Main trial site:
Royal Infirmary Edinburgh
Diagnostics devices play an important part in the clinical assessment of a patient’s health and treatment. The purpose of the study is the evaluation of a new diagnostic platform developed by LumiraDx. The evaluation is focused around various biomarkers useful in the emergency settings.
Primary Objective: evaluation of diagnostic platform with biomarkers useful in emergency settings.
Sample: Patients over 18 years old presenting to the Emergency Department with mainly symptoms of cardiovascular conditions.
Trial Design: Prospective observational (cohort) feasibility study
Chief Investigator
Professor Alasdair Gray
Honorary Professor of Emergency Medicine & Clinical Director of the Emergency Department
Research Team
Caroline Blackstock
AMU Senior Research Nurse
Julia Grahamslaw
Lead Research Nurse
Rachel O'Brien
Lead Research Nurse
Fiona McCurrach
Senior Research Nurse
Alison Williams
Senior Research Nurse
Clare Moceivei
Research Nurse- Bank Staff
Nicky Freeman
Senior Research Nurse
Kayleigh Craig
Research Nurse
Fraser Craig
Clinical Trial Assistant
Claire Cheyne
Senior Research Nurse
More EMERGE Trials
Diagnostics devices play an important part in the clinical assessment of a patient’s health and treatment. The purpose of the study is the evaluation of a new diagnostic platform developed by LumiraDx. The evaluation is focused around various biomarkers useful in the emergency settings.
NOVEL Study
Collection of venous and capillary blood samples for the evaluation of new diagnostic devices for cardiovascular conditions
DASH Trial
DASH is a randomised clinical trial investigating a treatment to reverse the effects of blood-thinning medications.